Monte Rosa Therapeutics Inc (GLUE) — Financial Flexibility Index
Monte Rosa Therapeutics Inc (GLUE) has a Financial Flexibility Index of -0.17x as of March 2026. Free cash flow of $-35.50 Million (operating CF $-37.37 Million minus capex $1.87 Million) represents 0% of total liabilities ($214.51 Million). Check GLUE capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Monte Rosa Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Monte Rosa Therapeutics Inc across 7 annual periods. See Monte Rosa Therapeutics Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Monte Rosa Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Monte Rosa Therapeutics Inc. For the full company profile including market capitalisation, see market value of Monte Rosa Therapeutics Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.08x | $-18.10 Million | $-22.80 Million | $215.60 Million | ▼ -139.4% |
| 2024 | 0.21x | $45.98 Million | $42.00 Million | $215.80 Million | ▲ +207.1% |
| 2023 | -0.20x | $-24.76 Million | $-43.80 Million | $124.50 Million | ▲ +82.3% |
| 2022 | -1.12x | $-79.56 Million | $-92.47 Million | $70.98 Million | ▲ +57.5% |
| 2021 | -2.64x | $-49.63 Million | $-59.36 Million | $18.81 Million | ▼ -1216.1% |
| 2020 | -0.20x | $-19.66 Million | $-23.05 Million | $98.11 Million | ▲ +2.7% |
| 2019 | -0.21x | $-4.79 Million | $-6.17 Million | $23.24 Million | — |